Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1934 1
1955 1
1956 1
1964 2
1965 2
1967 2
1968 1
1969 2
1972 2
1977 1
1978 2
1979 1
1980 2
1981 1
1984 2
1985 2
1986 4
1987 3
1988 6
1989 6
1990 3
1991 4
1992 2
1993 4
1995 4
1996 9
1997 5
1998 14
1999 6
2000 10
2001 9
2002 9
2003 10
2004 9
2005 13
2006 17
2007 24
2008 13
2009 25
2010 20
2011 23
2012 15
2013 14
2014 14
2015 11
2016 12
2017 21
2018 13
2019 13
2020 21
2021 18
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

407 results
Results by year
Filters applied: . Clear all
Page 1
MDM2 inhibition: an important step forward in cancer therapy.
Konopleva M, Martinelli G, Daver N, Papayannidis C, Wei A, Higgins B, Ott M, Mascarenhas J, Andreeff M. Konopleva M, et al. Among authors: higgins b. Leukemia. 2020 Nov;34(11):2858-2874. doi: 10.1038/s41375-020-0949-z. Epub 2020 Jul 10. Leukemia. 2020. PMID: 32651541 Review.
BRD4-mediated repression of p53 is a target for combination therapy in AML.
Latif AL, Newcombe A, Li S, Gilroy K, Robertson NA, Lei X, Stewart HJS, Cole J, Terradas MT, Rishi L, McGarry L, McKeeve C, Reid C, Clark W, Campos J, Kirschner K, Davis A, Lopez J, Sakamaki JI, Morton JP, Ryan KM, Tait SWG, Abraham SA, Holyoake T, Higgins B, Huang X, Blyth K, Copland M, Chevassut TJT, Keeshan K, Adams PD. Latif AL, et al. Among authors: higgins b. Nat Commun. 2021 Jan 11;12(1):241. doi: 10.1038/s41467-020-20378-8. Nat Commun. 2021. PMID: 33431824 Free PMC article.
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.
Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H, Spevak W, Zhang C, Zhang Y, Habets G, Burton EA, Wong B, Tsang G, West BL, Powell B, Shellooe R, Marimuthu A, Nguyen H, Zhang KY, Artis DR, Schlessinger J, Su F, Higgins B, Iyer R, D'Andrea K, Koehler A, Stumm M, Lin PS, Lee RJ, Grippo J, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, Chapman PB, Flaherty KT, Xu X, Nathanson KL, Nolop K. Bollag G, et al. Among authors: higgins b. Nature. 2010 Sep 30;467(7315):596-9. doi: 10.1038/nature09454. Nature. 2010. PMID: 20823850 Free PMC article. Clinical Trial.
Programming Isotype-Specific Plasma Cell Function.
Higgins BW, McHeyzer-Williams LJ, McHeyzer-Williams MG. Higgins BW, et al. Trends Immunol. 2019 Apr;40(4):345-357. doi: 10.1016/j.it.2019.01.012. Epub 2019 Mar 4. Trends Immunol. 2019. PMID: 30846256 Free PMC article. Review.
Pharmacological management of hypertension.
Higgins B, Williams B; Guideline Development Group. Higgins B, et al. Clin Med (Lond). 2007 Dec;7(6):612-6. doi: 10.7861/clinmedicine.7-6-612. Clin Med (Lond). 2007. PMID: 18193713 Free PMC article. Review.
Bench-to-bedside review: Permissive hypercapnia.
O'Croinin D, Ni Chonghaile M, Higgins B, Laffey JG. O'Croinin D, et al. Among authors: higgins b. Crit Care. 2005 Feb;9(1):51-9. doi: 10.1186/cc2918. Epub 2004 Aug 5. Crit Care. 2005. PMID: 15693984 Free PMC article. Review.
Future Trends in Nebulized Therapies for Pulmonary Disease.
McCarthy SD, González HE, Higgins BD. McCarthy SD, et al. Among authors: higgins bd. J Pers Med. 2020 May 10;10(2):37. doi: 10.3390/jpm10020037. J Pers Med. 2020. PMID: 32397615 Free PMC article. Review.
Automated image processing pipeline for adaptive optics scanning light ophthalmoscopy.
Salmon AE, Cooper RF, Chen M, Higgins B, Cava JA, Chen N, Follett HM, Gaffney M, Heitkotter H, Heffernan E, Schmidt TG, Carroll J. Salmon AE, et al. Among authors: higgins b. Biomed Opt Express. 2021 May 7;12(6):3142-3168. doi: 10.1364/BOE.418079. eCollection 2021 Jun 1. Biomed Opt Express. 2021. PMID: 34221651 Free PMC article.
407 results